Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients.
Lancet Infect Dis
; 23(8): e266-e267, 2023 08.
Article
in En
| MEDLINE
| ID: mdl-37352879
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19 Vaccines
/
COVID-19
Limits:
Humans
Language:
En
Journal:
Lancet Infect Dis
Journal subject:
DOENCAS TRANSMISSIVEIS
Year:
2023
Document type:
Article
Country of publication:
United States